author-photo

Meaghan P. Granger

University of Texas Southwestern Medical Center

3

Papers

6

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2431: Enrichment of targetable mutations in the relapsed neuroblastoma genome

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Fenretinide (4-HPR)/Lym-X-Sorb (LXS) oral powder plus ketoconazole in patients with high-risk (HR) recurrent or resistant neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) Consortium trial.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)